U.S. Pharmaceuticals & Biotech Most Popular Stocks

Acurx Pharmaceuticals

Market Cap: US$6.1m

A clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States.

Bakhu Holdings

Market Cap: US$6.0m

Produces, manufactures, and sells cannabis-related byproducts for medical, food additive, and recreational use.

cbdMD

Market Cap: US$6.0m

Produces and distributes various cannabidiol (CBD) products in the United States.

Enzon Pharmaceuticals

Market Cap: US$5.9m

Does not have significant operations.

Unified Global

Market Cap: US$5.9m

Operates as a vertically integrated cannabis company in Canada and the United States.

Aptevo Therapeutics

Market Cap: US$5.9m

A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.

60 Degrees Pharmaceuticals

Market Cap: US$5.7m

A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.

Titan Pharmaceuticals

Market Cap: US$5.7m

Does not have significant operations.

Galecto

Market Cap: US$5.6m

A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.

Clearmind Medicine

Market Cap: US$5.6m

A clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.

Mosaic ImmunoEngineering

Market Cap: US$5.6m

A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.

RedHill Biopharma

Market Cap: US$5.6m

A specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.

Mainz Biomed

Market Cap: US$5.5m

Develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe.

Pasithea Therapeutics

Market Cap: US$5.5m

A clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers.

CordovaCann

Market Cap: US$5.5m

Engages in identifying, funding, developing, and managing operations in the cannabis value chain business.

Mystic Holdings

Market Cap: US$5.5m

Through its subsidiaries, engages in the cultivation, production, and wholesale of medical and recreational cannabis in Nevada, the United States.

Oragenics

Market Cap: US$5.4m

A development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States.

GRI Bio

Market Cap: US$5.4m

A clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States.

Filament Health

Market Cap: US$5.2m

Operates as a clinical-stage natural psychedelic drug development company in Canada.

Cannabis Bioscience International Holdings

Market Cap: US$5.2m

Cannabis Bioscience International Holdings, Inc.

WEED

Market Cap: US$5.1m

Focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia.

Xenetic Biosciences

Market Cap: US$5.0m

A biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.

Aditxt

Market Cap: US$4.9m

A commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health.

Onconetix

Market Cap: US$4.9m

A biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology in the United States, European Union, and Non-European Union.

CNS Pharmaceuticals

Market Cap: US$4.8m

A clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors.

Bounce Mobile Systems

Market Cap: US$4.7m

Delex Healthcare Group, Inc. engages in the development and distribution of pharmaceutical and healthcare products in Asia and the Philippines.

Shuttle Pharmaceuticals Holdings

Market Cap: US$4.7m

A clinical stage pharmaceutical company, develops novel therapies to cure cancers.

GP Solutions

Market Cap: US$4.7m

Provides growing systems for growing specialty and leaf crops, and herbs.

Spruce Biosciences

Market Cap: US$4.7m

A biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.

Jaguar Health

Market Cap: US$4.7m

A commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress.

Rafarma Pharmaceuticals

Market Cap: US$4.6m

A multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia.

National Graphite

Market Cap: US$4.6m

Through its subsidiary, Biotech Development Corp., operates as a biopharmaceutical risk/cost-sharing company.

Valeo Pharma

Market Cap: US$4.6m

A specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceuticals and hospital specialty products for unmet medical needs in Canada.

Reflect Scientific

Market Cap: US$4.5m

Through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide.

InMed Pharmaceuticals

Market Cap: US$4.4m

A clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States.

Raphael Pharmaceutical

Market Cap: US$4.3m

A pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids.